1. Home
  2. Directory
  3. Ohio
  4. Cleveland
  5. Internal Medicine
  6. NPI Profile
  7. Prescriptions 1043483399

DR. SPARSHA SARALAYA M.D
Prescription History 1043483399
Internal Medicine in Cleveland, OH

NPI Status: Active since April 08, 2008

Contact Information

18200 LORAIN AVE
FAIRVIEW HOSPITAL
CLEVELAND, OH
ZIP 44111
Phone: (216) 476-7029

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. SPARSHA SARALAYA M.D, an active Internal Medicine specialist practicing in Cleveland, OH. Our medical registry currently tracks 3 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 43 documented patient claims. Among these therapy options, the most frequently utilized medication is Pantoprazole Sodium, which accounts for 17 claims alone.

Medication Index

E
M
P
No matching medications currently found on file.

Eliquis

Generic Formulation: ApixabanSpecialty: Hospitalist
Provider Metrics Summary
Total Claims 13
30-Day Fills 17.0
Days Supply 510
OH State Average Benchmarks
Peer Average Claims89.0
Peer Average 30-Day Fills138.4
Peer Average Days Supply3,835
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 85.4% less volume than the regional standard for practitioners inside OH. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $9,902.48 across this reporting matrix range.

Provider Avg Cost Per Claim

$761.73

State Avg Cost Per Claim

$779.27

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Apixaban is used to prevent serious blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip/knee replacement surgery. With atrial fibrillation, part of the heart does not beat the way it should. This can lead to blood clots forming, which can travel to other parts of your body (such as the lungs or legs) or increase your risk for stroke. In the United States, apixaban is also approved to treat certain types of blood clots (deep vein thrombosis-DVT, pulmonary embolus-PE) and to prevent them from forming again. Apixaban is an anticoagulant that works by blocking certain clotting proteins in your blood.

Meclizine Hcl

Generic Formulation: Meclizine HclSpecialty: Hospitalist
Provider Metrics Summary
Total Claims 13
30-Day Fills 13.0
Days Supply 119
OH State Average Benchmarks
Peer Average Claims24.0
Peer Average 30-Day Fills29.6
Peer Average Days Supply657
Conservative Utilization

This provider writes prescriptions for this formulation 45.8% less frequently than the standard regional baseline metric for practitioners inside OH. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $50.72 across this reporting matrix range.

Provider Avg Cost Per Claim

$3.90

State Avg Cost Per Claim

$13.03

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Meclizine is an antihistamine that is used to prevent and treat nausea, vomiting, and dizziness caused by motion sickness. It may also be used to reduce dizziness and loss of balance (vertigo) caused by inner ear problems.

Pantoprazole Sodium

Generic Formulation: Pantoprazole SodiumSpecialty: Hospitalist
Provider Metrics Summary
Total Claims 17
30-Day Fills 17.0
Days Supply 510
OH State Average Benchmarks
Peer Average Claims86.0
Peer Average 30-Day Fills169.2
Peer Average Days Supply4,953
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 80.2% less volume than the regional standard for practitioners inside OH. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $174.61 across this reporting matrix range.

Provider Avg Cost Per Claim

$10.27

State Avg Cost Per Claim

$15.75

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.

Therapeutic Applications

Pantoprazole is used to treat certain stomach and esophagus problems (such as acid reflux). It works by decreasing the amount of acid your stomach makes. This medication relieves symptoms such as heartburn, difficulty swallowing, and cough. It helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Pantoprazole belongs to a class of drugs known as proton pump inhibitors (PPIs).

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like DR. SPARSHA SARALAYA M.D provides transparency into local medical care patterns within Cleveland, OH.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Internal Medicine** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.